Case report highlights optic neuritis and panuveitis from pembrolizumab, indicating vital diagnostic steps.
To describe a rare case of pembrolizumab-induced bilateral optic neuritis with panuveitis and provide a comprehensive review of literature to highlight key diagnostic and management principles for this vision-threatening immune-related adverse event (irAE).
No takes yet. Share an insight, caveat, or question.
Almomani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: